ARVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.23%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $404,488.85

Arvinas Insider Trading History Chart

Arvinas Share Price & Price History

^$18.48

▲ +0.65 (3.65%)

As of 12/20/2024 06:15 PM ET

Days: 30 | 90 | 365

Missed Nvidia? Buy Elon Musk’s “Silent Partner”

From Brownstone Research | Ad

In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.

So please click here to see the details because a lot of people could get rich.

Arvinas Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/23/2024	John G. Houston	CEO	Sell	5,196	$47.05	$244,471.80	1,036,681
2/23/2024	Ronald Peck	Insider	Sell	1,699	$47.05	$79,937.95	67,516
2/23/2024	Sean A. Cassidy	CFO	Sell	1,702	$47.05	$80,079.10	181,916
8/11/2023	Ronald Peck	Insider	Sell	1,324	$24.39	$32,292.36	29,965
3/1/2023	Ian Taylor	Insider	Sell	1,051	$29.53	$31,036.03	101,721
3/1/2023	John G. Houston	CEO	Sell	5,878	$29.53	$173,577.34	917,427
3/1/2023	Sean A. Cassidy	CFO	Sell	1,745	$29.53	$51,529.85	183,618
8/12/2022	Ronald Peck	Insider	Sell	1,258	$68.99	$86,789.42	8,154
4/14/2022	Briggs Morrison	Director	Sell	20,960	$66.44	$1,392,582.40	19,976
3/11/2022	Sean A. Cassidy	CFO	Sell	15,000	$70.00	$1,050,000.00
3/4/2022	Ian Taylor	Insider	Sell	869	$63.94	$55,563.86
3/4/2022	John G. Houston	CEO	Sell	6,024	$63.94	$385,174.56
3/4/2022	Sean A. Cassidy	CFO	Sell	1,593	$63.94	$101,856.42
2/15/2022	Ian Taylor	Insider	Sell	20,000	$73.02	$1,460,400.00
1/14/2022	Briggs Morrison	Director	Sell	20,960	$65.55	$1,373,928.00

AI breakthrough about to upend industry

From Porter & Company | Ad

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

I urge you to watch it now.

SEC Filings (Institutional Ownership Changes) for Arvinas (NASDAQ:ARVN)

95.19% of Arvinas stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Arvinas Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/27/2024	Franklin Resources Inc.	69,190	$1.78M	0.0%	+11.6%	0.101%
11/16/2024	Geode Capital Management LLC	1,519,334	$37.43M	0.0%	-1.5%	2.211%
11/15/2024	M&T Bank Corp	27,137	$0.67M	0.0%	+53.5%	0.039%
11/15/2024	Barclays PLC	121,699	$3M	0.0%	+198.9%	0.177%
11/15/2024	Nomura Asset Management Co. Ltd.	90,870	$2.24M	0.0%	+36.3%	0.132%
11/15/2024	XTX Topco Ltd	18,401	$0.45M	0.0%	N/A	0.027%
11/15/2024	Zacks Investment Management	89,827	$2.21M	0.0%	+9.8%	0.131%
11/15/2024	Wellington Management Group LLP	32,789	$0.81M	0.0%	+23.9%	0.048%
11/15/2024	State Street Corp	1,643,727	$40.49M	0.0%	-3.3%	2.392%
11/15/2024	RTW Investments LP	2,782,329	$68.53M	1.0%	-6.3%	4.049%
11/15/2024	Parkman Healthcare Partners LLC	96,183	$2.37M	0.3%	-23.2%	0.140%
11/15/2024	HighVista Strategies LLC	58,001	$1.43M	0.5%	+13.5%	0.084%
11/15/2024	ArrowMark Colorado Holdings LLC	1,244,450	$30.65M	0.4%	+1.4%	1.811%
11/15/2024	Baker BROS. Advisors LP	405,576	$9.99M	0.1%	N/A	0.590%
11/14/2024	Bellevue Group AG	2,386,600	$58.78M	1.0%	-0.2%	3.473%
11/14/2024	Wasatch Advisors LP	435,943	$10.74M	0.1%	+58.3%	0.634%
11/14/2024	Braidwell LP	1,284,472	$31.64M	0.9%	+148.3%	1.869%
11/14/2024	Verition Fund Management LLC	38,631	$0.95M	0.0%	-57.7%	0.056%
11/14/2024	PEAK6 Investments LLC	15,000	$0.37M	0.0%	+42.9%	0.022%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	430,484	$10.60M	0.0%	-0.2%	0.627%
11/13/2024	BNP Paribas Financial Markets	37,349	$0.92M	0.0%	-55.9%	0.054%
11/13/2024	Quantbot Technologies LP	4,367	$0.11M	0.0%	+147.3%	0.006%
11/13/2024	FMR LLC	2,883,604	$71.02M	0.0%	+7.6%	4.197%
11/13/2024	The Manufacturers Life Insurance Company	90,406	$2.23M	0.0%	-4.9%	0.132%
11/12/2024	Algert Global LLC	168,061	$4.14M	0.1%	+278.1%	0.245%
11/12/2024	Charles Schwab Investment Management Inc.	530,669	$13.07M	0.0%	-2.5%	0.772%
11/9/2024	Intech Investment Management LLC	14,226	$0.35M	0.0%	N/A	0.021%
11/5/2024	Victory Capital Management Inc.	46,520	$1.15M	0.0%	-13.7%	0.068%
10/25/2024	China Universal Asset Management Co. Ltd.	13,203	$0.33M	0.0%	+64.2%	0.019%
10/25/2024	abrdn plc	78,585	$1.94M	0.0%	+27.8%	0.115%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,483	$61K	0.0%	+21.5%	0.004%
10/23/2024	E. Ohman J or Asset Management AB	29,830	$0.74M	0.0%	+20.1%	0.044%
10/23/2024	Assenagon Asset Management S.A.	139,741	$3.44M	0.0%	N/A	0.204%
10/23/2024	Hennion & Walsh Asset Management Inc.	64,125	$1.58M	0.1%	-2.7%	0.094%
10/19/2024	Allspring Global Investments Holdings LLC	7,371	$0.18M	0.0%	-48.4%	0.011%
10/16/2024	nVerses Capital LLC	1,600	$39K	0.0%	N/A	0.002%
10/10/2024	Exchange Traded Concepts LLC	6,659	$0.16M	0.0%	+37.0%	0.010%
10/5/2024	Handelsbanken Fonder AB	19,525	$0.48M	0.0%	+17.4%	0.029%
10/3/2024	SG Americas Securities LLC	9,860	$0.24M	0.0%	-88.5%	0.014%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	60,500	$1.61M	0.0%	-18.2%	0.088%
8/16/2024	Perceptive Advisors LLC	1,027,749	$27.36M	0.7%	-16.9%	1.502%
8/16/2024	Algert Global LLC	44,448	$1.18M	0.0%	-7.8%	0.065%
8/15/2024	The Manufacturers Life Insurance Company	95,105	$2.53M	0.0%	-20.4%	0.139%
8/15/2024	Millennium Management LLC	200,199	$5.33M	0.0%	-17.8%	0.293%
8/14/2024	Squarepoint Ops LLC	118,899	$3.17M	0.0%	+45.2%	0.174%
8/14/2024	Marshall Wace LLP	20,200	$0.54M	0.0%	N/A	0.030%
8/14/2024	Magnetar Financial LLC	41,992	$1.12M	0.0%	+112.7%	0.061%
8/14/2024	ProShare Advisors LLC	10,980	$0.29M	0.0%	-20.6%	0.016%
8/14/2024	Profund Advisors LLC	15,954	$0.43M	0.0%	+47.6%	0.023%
8/13/2024	Sei Investments Co.	26,594	$0.71M	0.0%	+8.5%	0.039%
8/12/2024	Seven Eight Capital LP	39,239	$1.05M	0.1%	+576.0%	0.057%
8/12/2024	Hsbc Holdings PLC	13,238	$0.34M	0.0%	+71.3%	0.019%
8/12/2024	Amalgamated Bank	2,223	$59K	0.0%	+29.6%	0.003%
8/9/2024	Edgestream Partners L.P.	9,311	$0.25M	0.0%	+16.3%	0.014%
8/9/2024	Renaissance Technologies LLC	275,400	$7.33M	0.0%	-23.9%	0.402%
8/9/2024	Dimensional Fund Advisors LP	463,935	$12.35M	0.0%	+6.8%	0.678%
8/8/2024	Federated Hermes Inc.	176,352	$4.69M	0.0%	+2.6%	0.258%
8/7/2024	Headlands Technologies LLC	16,837	$0.45M	0.0%	N/A	0.025%
8/6/2024	Quest Partners LLC	1,574	$42K	0.0%	N/A	0.002%
8/6/2024	Los Angeles Capital Management LLC	28,422	$0.76M	0.0%	-4.9%	0.041%
8/6/2024	Candriam S.C.A.	610,458	$16.25M	0.1%	+32.0%	0.889%
8/5/2024	Arizona State Retirement System	13,386	$0.36M	0.0%	-15.7%	0.019%
8/5/2024	Victory Capital Management Inc.	53,912	$1.44M	0.0%	+38.3%	0.079%
8/3/2024	TD Asset Management Inc	91,548	$2.44M	0.0%	-54.1%	0.133%
8/1/2024	Rhumbline Advisers	90,229	$2.40M	0.0%	+26.7%	0.132%
7/29/2024	Principal Financial Group Inc.	11,090	$0.30M	0.0%	-16.7%	0.016%
7/29/2024	Panagora Asset Management Inc.	256,658	$6.83M	0.0%	+57.4%	0.375%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,062	$0.27M	0.0%	+30.7%	0.015%
7/26/2024	Allspring Global Investments Holdings LLC	14,298	$0.38M	0.0%	+13.7%	0.021%
7/26/2024	Bank of New York Mellon Corp	235,096	$6.26M	0.0%	+32.6%	0.344%
7/25/2024	Banque Pictet & Cie SA	82,369	$2.19M	0.0%	-3.0%	0.120%
7/20/2024	Hennion & Walsh Asset Management Inc.	65,907	$1.75M	0.1%	+6.5%	0.096%
7/12/2024	SG Americas Securities LLC	86,096	$2.29M	0.0%	+137.2%	0.126%
7/10/2024	Contravisory Investment Management Inc.	6,938	$0.19M	0.0%	N/A	0.010%
5/29/2024	Opaleye Management Inc.	330,000	$13.62M	3.0%	+25.1%	0.482%
5/17/2024	Castleark Management LLC	76,990	$3.18M	0.1%	+7.6%	0.113%
5/16/2024	California State Teachers Retirement System	57,059	$2.36M	0.0%	+17.5%	0.083%
5/16/2024	Jacobs Levy Equity Management Inc.	10,450	$0.43M	0.0%	-77.7%	0.015%
5/16/2024	Janus Henderson Group PLC	32,429	$1.34M	0.0%	+55.1%	0.047%
5/16/2024	Kennedy Capital Management LLC	67,703	$2.80M	0.1%	N/A	0.099%
5/15/2024	Bellevue Group AG	2,390,800	$98.69M	1.5%	-4.7%	3.494%
5/15/2024	Price T Rowe Associates Inc. MD	4,368,418	$180.33M	0.0%	+14.0%	6.384%
5/15/2024	Magnetar Financial LLC	19,747	$0.82M	0.0%	N/A	0.029%
5/15/2024	Lazard Asset Management LLC	3,586	$0.15M	0.0%	-23.3%	0.005%
5/14/2024	CANADA LIFE ASSURANCE Co	17,726	$0.73M	0.0%	-13.2%	0.026%
5/14/2024	American International Group Inc.	24,857	$1.03M	0.0%	+1.8%	0.036%
5/13/2024	Seven Eight Capital LP	5,805	$0.24M	0.0%	-80.0%	0.008%
5/11/2024	Edgestream Partners L.P.	8,006	$0.33M	0.0%	N/A	0.012%
5/10/2024	Vanguard Group Inc.	6,299,556	$260.05M	0.0%	+29.9%	9.222%
5/9/2024	State Board of Administration of Florida Retirement System	16,670	$0.69M	0.0%	+18.4%	0.024%
5/8/2024	ProShare Advisors LLC	13,832	$0.57M	0.0%	+18.8%	0.020%
5/8/2024	Russell Investments Group Ltd.	5,032	$0.21M	0.0%	-51.2%	0.007%
5/7/2024	Sei Investments Co.	24,501	$1.01M	0.0%	+219.4%	0.036%
5/7/2024	Swiss National Bank	114,100	$4.71M	0.0%	+27.5%	0.167%
5/7/2024	SG Americas Securities LLC	36,297	$1.50M	0.0%	+462.2%	0.053%
5/3/2024	BI Asset Management Fondsmaeglerselskab A S	1,074	$44K	0.0%	N/A	0.002%
5/2/2024	FORA Capital LLC	18,895	$0.78M	0.1%	-11.0%	0.028%
5/2/2024	Nordea Investment Management AB	276,482	$11.56M	0.0%	-0.8%	0.405%
5/1/2024	BNP Paribas Financial Markets	147,255	$6.08M	0.0%	-25.3%	0.216%
4/29/2024	Principal Financial Group Inc.	13,307	$0.55M	0.0%	+3.8%	0.019%

Data available starting January 2016

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 1/2 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.

Today's Range

Now: $18.48

$17.53

$18.70

50 Day Range

MA: $24.83

$17.83

$28.04

52 Week Range

Now: $18.48

$17.37

$53.08

Volume

1,763,635 shs

Average Volume

738,855 shs

Market Capitalization

$1.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.82

Who are the company insiders with the largest holdings of Arvinas?: Arvinas' top insider investors include:
John G Houston (CEO)
Sean A Cassidy (CFO)
Ian Taylor (Insider)
Ronald Peck (Insider)
Learn More about top insider investors at Arvinas.
Who are the major institutional investors of Arvinas?: Arvinas' top institutional shareholders include:
FMR LLC — 4.20%
RTW Investments LP — 4.05%
Bellevue Group AG — 3.47%
State Street Corp — 2.39%
Geode Capital Management LLC — 2.21%
Braidwell LP — 1.87%
Learn More about top institutional investors of Arvinas stock.
Which major investors are selling Arvinas stock?: Within the last quarter, ARVN stock was sold by these institutional investors:
RTW Investments LP
SG Americas Securities LLC
State Street Corp
Verition Fund Management LLC
BNP Paribas Financial Markets
Parkman Healthcare Partners LLC
Geode Capital Management LLC
Charles Schwab Investment Management Inc.
Within the last year, company insiders that have sold Arvinas company stock include:
John G Houston (CEO)
Sean A Cassidy (CFO)
Ian Taylor (Insider)
Learn More investors selling Arvinas stock.
Which major investors are buying Arvinas stock?: Within the last quarter, ARVN stock was acquired by institutional investors including:
Braidwell LP
Baker BROS. Advisors LP
FMR LLC
Wasatch Advisors LP
Assenagon Asset Management S.A.
Algert Global LLC
LMR Partners LLP
Barclays PLC